Your browser doesn't support javascript.
loading
An assessment of legislative responses to cancer in Brazil's House of Representatives.
Corrêa, Lucas Hernandes; Siqueira, Marina Martins; Maluf, Fernando Cotait.
Afiliação
  • Corrêa LH; Hospital Israelita Albert Einstein, Center for Studies and Promotion of Health Policies, São Paulo, Brazil.
  • Siqueira MM; Hospital Israelita Albert Einstein, Center for Studies and Promotion of Health Policies, São Paulo, Brazil. Electronic address: marina.siqueira@einstein.br.
  • Maluf FC; Hospital Israelita Albert Einstein, Oncology Department, São Paulo, Brazil.
J Cancer Policy ; 37: 100429, 2023 09.
Article em En | MEDLINE | ID: mdl-37391094
ABSTRACT

BACKGROUND:

Cancer is a public health issue in Brazil. To mitigate exposure to risk factors, change habits and ensure access to cancer care, an increasing number of bills are presented every year. This article analyzes the changes proposed in these bills, portraying how the representatives perceive and respond to the challenges imposed by cancer on the healthcare system and society.

METHODS:

Through a systematic search on the Brazilian House of Representatives website, this exploratory study examines cancer-related bills presented up to 2022.

RESULTS:

Of 1311 bills identified, 310 met the inclusion criteria and were categorized based on their content. The increasing annual number of cancer bills reflects the interest of representatives on the topic. The cancer types addressed correspond to the most prevalent ones, except for the colorectal. The most common strategy is primary prevention (n 129), proposing the reduction of risk factors exposure or the promotion of protective ones, followed by tertiary (n 106) and secondary (n 36) strategies, targeting, respectively, cancer treatment/management and its early diagnosis/detection. On the nature of proposed changes, most seek to implement increased healthcare access (n 125), production/sale (dis)incentives for goods containing carcinogens (n 60), and fiscal/financial (dis)incentives (n 53).

CONCLUSION:

The identified gaps - such as the limited use of data and evidence to support what is proposed, overlapping but fragmented efforts with previous bills, scarce efforts directly addressing the determinants of health, and the low rate of conversion to law - entails opportunities to advance the Legislative propositions. POLICY

SUMMARY:

To effectively respond to cancer-related challenges, is essential that the Legislative branch takes into account what is already being proposed or being left out, inputs from society, real-world data, and the results produced by the multisectoral policies in place.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 2_ODS3 Base de dados: MEDLINE Assunto principal: Política de Saúde / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Cancer Policy Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 2_ODS3 Base de dados: MEDLINE Assunto principal: Política de Saúde / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Cancer Policy Ano de publicação: 2023 Tipo de documento: Article